GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Current Ratio

Orion Pharma (DHA:ORIONPHARM) Current Ratio : 2.07 (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Orion Pharma's current ratio for the quarter that ended in Sep. 2024 was 2.07.

Orion Pharma has a current ratio of 2.07. It generally indicates good short-term financial strength.

The historical rank and industry rank for Orion Pharma's Current Ratio or its related term are showing as below:

DHA:ORIONPHARM' s Current Ratio Range Over the Past 10 Years
Min: 1.51   Med: 2.11   Max: 4.26
Current: 2.07

During the past 12 years, Orion Pharma's highest Current Ratio was 4.26. The lowest was 1.51. And the median was 2.11.

DHA:ORIONPHARM's Current Ratio is ranked better than
70.07% of 441 companies
in the Utilities - Independent Power Producers industry
Industry Median: 1.34 vs DHA:ORIONPHARM: 2.07

Orion Pharma Current Ratio Historical Data

The historical data trend for Orion Pharma's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Current Ratio Chart

Orion Pharma Annual Data
Trend Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.99 2.70 1.99 2.01 2.17

Orion Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.64 1.51 1.86 2.17 2.07

Competitive Comparison of Orion Pharma's Current Ratio

For the Utilities - Independent Power Producers subindustry, Orion Pharma's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma's Current Ratio Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Current Ratio distribution charts can be found below:

* The bar in red indicates where Orion Pharma's Current Ratio falls into.



Orion Pharma Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Orion Pharma's Current Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Current Ratio (A: Jun. 2024 )=Total Current Assets (A: Jun. 2024 )/Total Current Liabilities (A: Jun. 2024 )
=16853.385/7766.386
=2.17

Orion Pharma's Current Ratio for the quarter that ended in Sep. 2024 is calculated as

Current Ratio (Q: Sep. 2024 )=Total Current Assets (Q: Sep. 2024 )/Total Current Liabilities (Q: Sep. 2024 )
=17364.389/8376.847
=2.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orion Pharma  (DHA:ORIONPHARM) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Orion Pharma Current Ratio Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines